解读核酸结合蛋白2在脂质失调和肝细胞癌通过LKB1介导的线粒体功能障碍的进展中的作用
Chengchen Dai1, Yun Tong2, Nan Bai1
1Research Center of Clinical Medicine & Department of Clinical and Translational Research Center, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China; Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
核酸结合蛋白2 (NABP2) 通过破坏脂质代谢和抑制LKB1/AMPK通路,促进肝细胞癌 (HCC) 的进展. NABP2可以作为HCC的生物标志物和治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢过程中的代谢.
背景情况:
- 核酸结合蛋白2 (NABP2) 与肝细胞癌 (HCC) 的进展有关.
- 在HCC中NABP2的确切机制,特别是关于代谢途径的确切机制,尚未完全理解.
研究的目的:
- 研究NABP2在HCC发育和患者预后中的作用.
- 阐明NABP2在HCC中的功能背后的分子机制,包括其对新陈代谢和信号通路的影响.
主要方法:
- 在临床HCC样本中分析NABP2表达和与生存的相关性.
- 在体外和体外功能测试评估细胞增殖,迁移和脂质代谢.
- 研究NABP2与STUB1以及LKB1/AMPK信号通路的相互作用.
主要成果:
- 在HCC中NABP2过度表达,并与较差的患者存活率有关.
- NABP2增强瘤细胞的增殖和迁移,同时损害脂质代谢.
- NABP2招募STUB1来调节LKB1蛋白质稳定,抑制LKB1/AMPK轴,并导致线粒体功能障碍.
结论:
- 通过代谢重编程和抑制LKB1/AMPK通路,NABP2促进了HCC的进展.
- NABP2代表了HCC的潜在生物标志物和治疗标.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
相关概念视频
Regulation of Nuclear Protein Sorting
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
The Intrinsic Apoptotic Pathway
The Nucleolus
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
